Recent Reports


2010-03-11: Health Care IT Report
6 leading Analysts; and top management from 1 Sector Firm examine this vital industry in this 23 page report from The Wall Street Transcript.
More Information
Order this Report

2010-01-25: Medical Research, Diagnostic Substances, Life Science Tools Report
7 leading Analysts; and top management from 2 Sector Firms examine this vital industry in this 38 page report from The Wall Street Transcript.
More Information
Order this Report

2009-12-07: Consumer Health Services Report
7 leading Analysts; and top management from 2 Sector Firm examine this vital industry in this 53 page report from The Wall Street Transcript.
More Information
Order this Report

2009-11-02: Pharmaceuticals Report
3 leading Analysts; and top management from 16 Sector Firms examine this vital industry in this 76 page report from The Wall Street Transcript.
More Information
Order this Report

2009-10-19: Biotechnology Report
3 leading Analysts; 2 Money Managers; and top management from 12 Sector Firms examine this vital industry in this 70 page report from The Wall Street Transcript.
More Information
Order this Report

09.21.09: Medical Real Estate: Healthcare REITs, Long-Term Care Facilities & Hospitals Report
3 analysts and 6 sector firms examine the medical real estate segment in this 45 page report from The Wall Street Transcript.
More Information
Order this Report

09.21.09: Medical Devices Report
4 analysts and 7 sector firms examine the medical devices segment in this 41 page report from The Wall Street Transcript.
More Information
Order this Report

09.14.09: Medical Research Services Report
2 analysts, and 4 sector firms examine the medical research services segment in this 23 page report from The Wall Street Transcript.
More Information
Order this Report

Search TWST Online

TWST Newsletter

Give us your email address and receive the TWST Newsletter.



ROUNDTABLE FORUM: MEDICAL TECHNOLOGY: SMALL CAP STOCKS


Full article published: 09/20/1999


For Subscribers

Get this article online now!

Order just this article
TWST: Let's start by establishing the parameters of what constitutes small capitalization or, small to medium capitalization, medical technology stocks. Michael?
Mr. Mullen: I have generally thought of small cap as stocks with market caps of roughly 1 billion or less. We could stretch the definition to include the few medical device stocks with market caps up to 3 billion. Stocks at the other end of the spectrum, say under 400 million in market cap, are sometimes referred to as emerging growth. But for this discussion, let's just say 1 billion or less.

TWST: Rick, are we talking about companies under 1 billion, under 500 million? What are the smallest companies that you include in your universe?
Mr. Wise: The definition of less than 1 billion market cap for the small cap universe is a very good one. One challenge in this environment, in regard to the current stock market environment, is that many people are expanding that definition, and as I go around and talk to institutions, to my surprise, they sometimes consider smaller cap names or medium cap names in the 1-5 billion market cap range. This could just reflect the appreciation in the market. But certainly, in my mind, less than 1 billion for small caps is an accurate statement. We then have the emerging technology companies that are less than 100 million these days. So in conclusion, I believe that the small cap universe can be summed up as, beauty or size , is in the eye of the beholder'.

 

Tickers included in this excerpt: ACN, BDX, BEAM, CBMI, DGX, DSCP, GDT, IDXX, KERA, MDT, MNMD, NOVT, OCLR, PERC, SMPX, STJ, SYK, VISX, VMSI, WJCO, XOMD

 

For more information call (212) 952 7433. The Wall Street Transcript does not endorse any of the comments made by interviewees, and does not make stock recommendations.